1. Trang chủ
  2. » Y Tế - Sức Khỏe

Lydyard, peter m case studies in infectious disease plasmodium spp garland science (2010)

22 43 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 22
Dung lượng 1,93 MB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

Book Cover......Page 1 Title......Page 2 Copyright......Page 3 Preface to Case Studies in Infectious Disease......Page 4 Table of Contents......Page 5 Plasmodium spp.......Page 8 Answers to Multiple Choice Questions......Page 21 cover Author(s): Lydyard, Peter M Publisher: Garland Science, Year: 2010 ISBN: 9781136986062,9780815341420,0203854004,0815341423,9780203854006,9781136986017,1136986014,9781136986055,1136986057,1136986065

Trang 2

Peter M Lydyard

Michael F Cole

John Holton William L Irving

Nino Porakishvili

Pradhib Venkatesan

Katherine N Ward

Plasmodium spp.

Trang 3

Vice President: Denise Schanck

Editor: Elizabeth Owen

Editorial Assistant: Sarah E Holland

Senior Production Editor: Simon Hill

Typesetting: Georgina Lucas

Cover Design: Andy Magee

Proofreader: Sally Huish

Indexer: Merrall-Ross International Ltd

©2010 by Garland Science, Taylor & Francis Group, LLC

This book contains information obtained from authentic and highly

regarded sources Reprinted material is quoted with permission, and

sources are indicated A wide variety of references are listed

Reasonable efforts have been made to publish reliable data and

information, but the author and the publisher cannot assume

responsibility for the validity of all materials or for the consequences of

their use All rights reserved No part of this book covered by the

copyright heron may be reproduced or used in any format in any form

or by any means—graphic, electronic, or mechanical, including

photocopying, recording, taping, or information storage and retrieval

systems—without permission of the publisher

The publisher makes no representation, express or implied, that the

drug doses in this book are correct Readers must check up to date

product information and clinical procedures with the manufacturers,

current codes of conduct, and current safety regulations

ISBN 978-0-8153-4142-0

Library of Congress Cataloging-in-Publication Data

Case studies in infectious disease / Peter M Lydyard [et al.].

p ; cm.

Includes bibliographical references.

SBN 978-0-8153-4142-0

1 Communicable diseases Case studies I Lydyard, Peter M.

[DNLM: 1 Communicable Diseases Case Reports 2 Bacterial

Infections Case Reports 3 Mycoses Case Reports 4 Parasitic

Diseases Case Reports 5 Virus Diseases Diseases Case Reports WC 100 C337 2009]

270 Madison Avenue, New York NY 10016, USA,

and 2 Park Square, Milton Park, Abingdon, OX14 4RN, UK

Visit our web site at http://www.garlandscience.com

Peter M Lydyard, Emeritus Professor of

Immunology, University College MedicalSchool, London, UK and HonoraryProfessor of Immunology, School ofBiosciences, University of Westminster,

London, UK Michael F Cole, Professor

of Microbiology & Immunology,Georgetown University School ofMedicine, Washington, DC, USA

John Holton, Reader and Honorary

Consultant in Clinical Microbiology,Windeyer Institute of Medical Sciences,University College London and UniversityCollege London Hospital Foundation Trust,

London, UK William L Irving, Professor

and Honorary Consultant in Virology,University of Nottingham and NottinghamUniversity Hospitals NHS Trust,

Nottingham, UK Nino Porakishvili,

Senior Lecturer, School of Biosciences,University of Westminster, London, UKand Honorary Professor, JavakhishviliTbilisi State University, Tbilisi, Georgia

Pradhib Venkatesan, Consultant in

Infectious Diseases, Nottingham UniversityHospitals NHS Trust, Nottingham, UK

Katherine N Ward, Consultant Virologist

and Honorary Senior Lecturer, UniversityCollege Medical School, London, UK andHonorary Consultant, Health ProtectionAgency, UK

ISBN 0-203-85400-4 Master e-book ISBN

This edition published in the Taylor & Francis e-Library, 2009

To purchase your own copy of this or any of Taylor & Francis or Routledge’s

collection of thousands of eBooks please go to www.eBookstore.tandf.co.uk

Trang 4

The idea for this book came from a successful course in a medical schoolsetting Each of the forty cases has been selected by the authors as beingthose that cause the most morbidity and mortality worldwide The casesthemselves follow the natural history of infection from point of entry ofthe pathogen through pathogenesis, clinical presentation, diagnosis, andtreatment We believe that this approach provides the reader with a logi-cal basis for understanding these diverse medically-important organisms Following the description of a case history, the same five sets of core ques-tions are asked to encourage the student to think about infections in acommon sequence The initial set concerns the nature of the infectiousagent, how it gains access to the body, what cells are infected, and how theorganism spreads; the second set asks about host defense mechanismsagainst the agent and how disease is caused; the third set enquires aboutthe clinical manifestations of the infection and the complications that canoccur; the fourth set is related to how the infection is diagnosed, and what

is the differential diagnosis, and the final set asks how the infection is aged, and what preventative measures can be taken to avoid the infection

man-In order to facilitate the learning process, each case includes summary let points, a reference list, a further reading list and some relevant reliablewebsites Some of the websites contain images that are referred to in thetext Each chapter concludes with multiple-choice questions for self-test-ing with the answers given in the back of the book

bul-In the contents section, diseases are listed alphabetically under thecausative agent A separate table categorizes the pathogens as bacterial,viral, protozoal/worm/fungal and acts as a guide to the relative involve-ment of each body system affected Finally, there is a comprehensive glos-sary to allow rapid access to microbiology and medical terms highlighted

in bold in the text All figures are available in JPEG and PowerPoint® mat at www.garlandscience.com/gs_textbooks.asp

for-We believe that this book would be an excellent textbook for any course inmicrobiology and in particular for medical students who need instantaccess to key information about specific infections

Trang 5

Case 1 Aspergillus fumigatus

Case 2 Borellia burgdorferi and related species

Case 3 Campylobacter jejuni

Case 4 Chlamydia trachomatis

Case 5 Clostridium difficile

Case 6 Coxiella burnetti

Case 7 Coxsackie B virus

Case 8 Echinococcus spp

Case 9 Epstein-Barr virus

Case 10 Escherichia coli

Case 11 Giardia lamblia

Case 12 Helicobacter pylori

Case 13 Hepatitis B virus

Case 14 Herpes simplex virus 1

Case 15 Herpes simplex virus 2

Case 16 Histoplasma capsulatum

Case 17 Human immunodeficiency virus

Case 18 Influenza virus

Case 19 Leishmania spp

Case 20 Leptospira spp

Case 21 Listeria monocytogenes

Case 22 Mycobacterium leprae

Case 23 Mycobacterium tuberculosis

Case 24 Neisseria gonorrhoeae

Case 25 Neisseria meningitidis

Case 33 Staphylococcus aureus

Case 34 Streptococcus mitis

Case 35 Streptococcus pneumoniae

Case 36 Streptococcus pyogenes

Case 37 Toxoplasma gondii

Case 38 Trypanosoma spp

Case 39 Varicella-zoster virus

Case 40 Wuchereia bancrofti

Table of Contents

The glossary for Case Studies in Infectious Disease can be found

at http://www.garlandscience.com/textbooks/0815341423.asp

Trang 6

Guide to the relative involvement of each body system affected

by the infectious organisms described in this book: the organisms are categorized into bacteria, viruses, and protozoa/fungi/worms

Organism Resp MS GI H/B GU CNS CV Skin Syst L/H

Trang 7

The rating system (+4 the strongest, +1 the weakest) indicates the greater to lesser involvement of the body system

KEY:

Resp = Respiratory: MS = Musculoskeletal: GI = Gastrointestinal

H/B = Hepatobiliary: GU = Genitourinary: CNS = Central Nervous System

Skin = Dermatological: Syst = Systemic: L/H = Lymphatic-Hematological

Trang 8

1 What is the causative agent, how does it enter the body and

how does it spread a) within the body and b) from person to

person?

Causative agent

The organism causing malaria is Plasmodium, a eukaryotic protozoan that

infects the erythrocytes of humans It has the characteristics of eukaryotes,

with a nucleus, mitochondria, endoplasmic reticulum, and so forth Until

recently four species of Plasmodium were identified as being able to infect

humans: P falciparum, P ovale, P vivax, and P malariae A simian

plasmod-ium, P knowlesi, has been recently proven infective to humans P

falci-parum is the most virulent species of malaria in humans All these species

have similar life cycles in which the organisms undergo both sexual and

asexual reproduction in the vector and host and alternate between

intracel-lular and extracelintracel-lular forms The female Anopheles mosquito is the vector

for malaria The risk of malaria transmission is therefore restricted to

those areas where mosquitoes can breed and where the parasite can

develop within the mosquito The maximum extent of malaria risk is

between approximately 60∞N and 30∞S (except areas higher than around

2500 meters), although this distribution has been reduced dramatically and

is currently restricted mainly to the tropics and subtropics – see

Epidemiology below

Entry and spread within the body

The transmission stage of Plasmodium is the sporozoite, which is injected

into the bloodstream of a human when the female Anopheles mosquito

takes a blood meal (Figure 1) The detailed life cycle is shown in Figure 2

Following the mosquito bite, at least some of the sporozoites remain in the

dermis for some time before entering the bloodstream and some pass into

draining lymph nodes Only a few dozen sporozoites are transmitted

dur-ing feeddur-ing but there is rapid translocation into the liver to begin the first

stage of disease

Liver stage (pre-erythrocytic stage)

The blood-borne sporozoites localize in the liver via the sinusoids, where

through their surface circumsporoite protein (CSP) they attach to the

Plasmodium spp.

A 26-year-old model went to see her doctor about 1 week

after returning from a job in the Gambia She complained

of an abrupt onset of bouts of shivering and feeling cold,

vomiting, rigors, and profuse sweating accompanied by a

headache and nausea On examination she was noted to

be pale with a temperature of 39.5∞C and hadtachycardia She gave a history of having taken anti-malarial tablets before and during her stay in the Gambiabut was admitted to hospital with a provisional diagnosis

of malaria

Figure 1 Anopheles funestus mosquito taking a blood meal from its human host This mosquito species, together with

Anopheles gambiae, is one of the two most important malaria vectors in Africa Note the blood passing through the proboscis

Trang 9

highly sulfated heparan sulfate proteoglycans (HSPGs) on the surface ofthe of hepatocytes Other membrane molecules are important for thisbinding The sporozoites actively enter the hepatocytes, (invade – rather

than are taken up passively by endocytosis) and here they increase in

number and develop into schizonts P vivax and P ovale also produce a

liver stage

erythrocytic stage

infective stage

diagnostic stage

2 3

O O

liver cell

infected liver cell

schizont

schizont

P falciparum

immature trophozoite (ring stage)

mature trophozoite

gametocyte development gametocytes

exflagellated microgametocyte

ookinete

schizont ruptures, merozoites released

Figure 2 The life cycle of Plasmodium (1) The mosquito

injects saliva containing sporozoites as it takes a blood meal and

the parasite localizes in the liver (liver stage), where it undergoes

a stage of development to produce a schizont in the infected

liver cell, which contains merozoites (2) P vivax and P ovale also

produce a resting stage within the liver cell called hypnozoites,

which can persist in the liver and result in relapses months or

even years later The dead liver cell breaks open and the shizont

ruptures (3) releasing merozoites into the bloodstream These

invade erythrocytes (erythrocytic stage) and undergo

developmental stages as trophozoites, which mature and

produce schizonts, at which stage the erythrocyte bursts

rupturing the shizonts to release further merozoites (4) Further

cycles of asexual development within uninfected erythrocytes occur, releasing more merozoites to infect further erythrocytes Differentiation of the immature trophozoite into male and female gametocytes occurs in some erythrocytes (5) and these are ingested when a mosquito takes a blood meal The male (microgametocyte – exflagellated) fertilizes the female macrogametocyte (6) to form a zygote within the intestine of the mosquito (vector stage) and this becomes an ookinete that invades the intestinal wall where it develops into an oocyte (7) The oocyte matures into sporozoites, which are released and migrate to the salivary gland of the mosquito Here they will be transmitted to a new human host when the mosquito takes a blood meal and the cycle starts again (1)

Trang 10

resting stage within the liver cell called hypnozoites, which are responsible

for the relapses that occur with these forms of malaria (see later) This

asexual stage takes up to 2 weeks Rupture of the liver cells releases the

schizonts into the bloodstream as merozoites (with about 10–40 000 being

released from the liver)

Erythrocytic stage

These invade and destroy erythrocytes giving rise to symptoms (see

com-plications later) The entry of the merozoites into erythrocytes is achieved

through attachment of a number of surface molecules (merozoite surface

proteins, MSPs) to structures on the erythrocyte, for example band 3

pro-tein for P falciparum P vivax has a specific reticular binding propro-tein to

enable it to attach and invade reticulocytes In addition, P vivax has

sur-face molecules (Duffy binding proteins – DBPs) that bind to Duffy blood

group antigens on the erythrocytes The lack of this antigen in some human

populations, mostly West Africans, explains their resistance to P vivax.

Within the erythrocyte, the merozoites undergo further development as a

trophozoite (seen as a ‘ring’ stage – see Figure 2) and then undergo

asex-ual reproduction to produce schizonts, at which stage the erythrocyte

bursts releasing merosomes containing 16–32 daughter merozoites into

the bloodstream

Each asexual cycle takes 44–48 hours, and is followed by cell rupture and

re-invasion steps that induce periodic waves of fever in the patient (see

Figure 3 and Section 3) This erythrocytic cycle may continue for months

or years However, in some erythrocytes the trophozoites differentiate into

male and female gametocytes and a mosquito taking a blood meal will take

up some of gametocyte-containing erythrocytes, heralding the sexual

developmental phase in the vector

Vector stage

Within the intestine of the insect, male (exflagellated microgametocytes)

and female gametes (macrogametocytes) fuse to become a zygote These

become an ookinete, which then invades the intestinal wall where it

develops into an oocyte The oocyte develops into thousands of

sporo-zoites, which then migrate to the mosquito’s salivary gland

Trang 11

Person to person spread

The sporozoites are injected into an individual when an infected female

Anopheles mosquito feeds and the whole cycle starts again

worsen-300 million carriers of the parasite Estimates made independently byothers using a combination of epidemiologic, geographic, and demo-graphic data have put the overall clinical episodes of malaria at up to 50%higher and 200% higher for areas outside Africa The higher values arebelieved to reflect the WHO’s reliance on passive national reporting forthese countries

Most malaria infections and deaths occur in sub-Saharan Africa, where it

is estimated to account for 80% of all clinical cases and about 90% of allpeople that carry the parasite Malaria deaths have been estimated at

800 000 per year in children and a child dies every 30 seconds! Asia, LatinAmerica, the Middle East, and parts of Europe are also affected Withincreasing international travel, there continues to be a rise in the number

of cases of malaria in travelers returning to nonmalarious areas fromcountries where malaria is endemic During the last decade, there hasbeen an average of 1843 cases of malaria in Great Britain each year The

global incidence of P falciparum is shown in Figure 4 Pregnancy has a

high risk of malaria An estimated 10 000 pregnant women and 200 000

of their infants die annually in sub-Saharan Africa as a result of malariainfection during pregnancy HIV-infected pregnant women are atincreased risk

Human genetic factors that decrease the infection rates of Plasmodium

As already mentioned, the absence of DBPs in most West Africans

pre-vents infection by P vivax, since it uses the Duffy blood group antigen as

a means of attachment Sickle cell trait (heterozygous for HbS with HbA)gives an increasing amount of immunological protection against malaria asyoung children grow during their first 10 years of life, although the mech-anism is currently unknown Glucose 6 phosphate dehydrogenase (G6PD)deficiency confers resistance to malaria; again, the mechanism is unknown

2 What is the host response to the infection and what is the disease pathogenesis?

Plasmodium has a number of ‘escape mechanisms’ that allow it to avoid the

immune response For example, it has numerous morphological formsthrough its life cycle (Section 1) that are found both extracellularly andintracelluarly The organism can also modify its surface receptors to bind

to hepatocytes (sporozoites) and erythrocytes (merozoites) In addition,

Ngày đăng: 17/12/2020, 15:43

TỪ KHÓA LIÊN QUAN

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN